Guardant Health, Inc. Common Stock (GH) is a publicly traded Healthcare sector company. As of July 5, 2026, GH trades at $167.98 with a market cap of $22.27B and a P/E ratio of -49.41. GH moved -1.44% today. Year to date, GH is +66.98%; over the trailing twelve months it is +234.75%. Its 52-week range spans $28.45 to $172.61. Analyst consensus is strong buy with an average price target of $146.63. Rallies surfaces GH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
21 analysts cover GH: 0 strong buy, 21 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $146.63.
| Metric | Value |
|---|---|
| Price | $167.98 |
| Market Cap | $22.27B |
| P/E Ratio | -49.41 |
| EPS | $-3.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $172.61 |
| 52-Week Low | $28.45 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.08B |
| Net Income | $-433.19M |
| Gross Margin | 64.90% |
21 analysts cover GH: 0 strong buy, 21 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $146.63.